NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Michael Knox runs a restaurant near Minneapolis. He said employees are afraid to come in, and even his regular customers have been absent.Read More